Epicardial adipose tissue (EAT) has morphological and physiological contiguity with the
myocardium and coronary arteries, making it a visceral fat deposit with some unique …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the West. Non-alcoholic steatohepatitis (NASH) is the progressive form of NAFLD and can …

Peroxisome proliferator-activated receptors (PPARs) are ligand dependent transcription
factors. The three mammalian PPARs are key regulators of fatty acid and lipoprotein …

Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a
cause of end‐stage liver disease, with increased mortality secondary to cirrhosis and its …

Abstract Aims/Introduction It is thought that adipocytokines contribute to the increased risk of
vascular complications in type 2 diabetes. However, there is still limited information on the …

Introduction: Several peptides are involved in the regulation of food intake and energy
expenditure, among which are leptin, adiponectin, ghrelin and neuropeptide Y (NPY). These …

Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease
today, and it has now emerged as the leading etiology of end-stage liver disease requiring …

Ezetimibe, an inhibitor of intestinal cholesterol absorption, can decrease total cholesterol
(TC), low density lipoprotein cholesterol (LDL-C), triglycerides (TGs) and apolipoprotein …

Background Several lines of evidence have indicated the insulin-sensitizing, anti-diabetic
and anti-atherosclerotic properties of adiponectin, as well as the inverse association …

Nonalcoholic steatohepatitis (NASH) is the most common cause of chronic liver disease in
the Western world. It can lead to cirrhosis and hepatocellular cancer, and is independently …